Skip to main content

Podcast

Hit Parade Review (8.12.2022)

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. This week the run down is based on popularity, measured by rheumatologist engagements on the website and social media.

The Great Unknowns (8.5.2022)

Dr. Jack Cush reviews the news, FDA approvals, journal articles from the past week on RheumNow; plus viewer questions. This week great hopes for vitamin D, the great unknows of CSA and the great big mess that is the gout.

QD Clinics - Still's Or Not - Part 2

QD197 - Still's (or Not) NEJM CPC https://youtu.be/_xnCaxeqidwQD198 - Still's (or Not) with Daily Fevers https://youtu.be/J1bezuA-f_sQD199 - Still's (or Not): an FUO Evaluation https://youtu.be/0qDijCAqEpQQD200 -

Social Media Questions (7.29.2022)

Dr. Jack Cush reviews the news, journal reports and rheumatologist cases from the past week on RheumNow.com. This podcast is brought to you by StillsNow.com - be sure to sign up for our monthly StillsNow email and Monthly StillsNow Podcast.

TNR Still's Now Journal Club - Pivotal Trials in SJIA & AOSD Approved Meds

This week's Stills disease Journal Club features expert discussants Drs. Olga Petryna, Daniel Lovell, Hermine Brunner and Jack Cush. Journal articles reviewed includes: - CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C.

Early, Aggressive & Seropositive (7.22.2022)

Early, Aggressive & Seropositive (7.22.2022) by Dr. Cush

Copy of TNR- Still's Now Journal Club - Seminal Articles from 1971 & 1973

Join Dr. Michael Weisman, Dr. Bella Mehta and Dr. Jack Cush in this live, one-hour Journal Club to discuss: 1. Still's disease in the adult. EGL Bywaters. Annals of Rheumatic Disease 1971 2. Juvenile rheumatoid arthritis presenting in the adult as fever of unknown origin. J Bujak, et al. Medicine 1973

Fever Pitch (7.15.2022)

Dr. Jack Cush reviews the new studies and drug approvals and new insights into febrile disorders from the past week on RheumNow.com

QD Clinics - Still's Or Not - Part 1

QD193 - Stills (or Not) MAS off of Tocilizumab https://youtu.be/xIco2Xdxf68QD194 - Stills (or Not) with Widespread Pain https://youtu.be/50BXYafkVZMQD 195 - Stills (or Not) with Hives https://youtu.be/f4tPMylrnpQ

ICYMI 2021 Rheumatology Year In Review

Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021. My Top 10 list 1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod 2. New FDA Indications 3. New Biologics for Lupus 4. Super "H" Hydroxychloroquine 5. Zoomatology 6. Avacopan 7. Tocilizumab 8. FDA & JAK inhibitor warnings 9.

Solving Stills Disease

Still's disease is the most common rheumatic cause of unknown fever in adults. This series by Dr. Jack Cush covers the definition, history, epidemiology, key manifestations and labs, diagnostic criteria, pathogenesis and the management of adult-onset Still's disease. Dr.

What Worries You, Masters You (7.1.2022)

Dr. Jack Cush reviews recent news, regulatory and guideline updates from the past week on RheumNow.com. Studies on methotrexate use, COVID vaccination, Supplements and vitamins, and arthrocentesis despite anticoagulation are discussed.
×